• BP meds: this simple change improves outcomes 

    Kirley, Kate; Sharma, Umang; Rowland, Kate (Family Physicians Inquiries Network, 2012-03)
    Advise patients with uncontrolled hypertension to take at least one of their blood pressure (BP) medications at bedtime instead of in the morning. Nighttime dosing leads to better control and lowers the risk of ...
  • Consider this strategy for upper GI bleeds 

    Frazer, Kevin; Kirley, Kate; Stevermer, James J. (Family Physicians Inquiries Network, 2013-09)
    Do not order transfusions of red blood cells for patients with acute upper gastrointestinal bleeding unless their hemoglobin level <7 g/dL. A: Based on a single randomized controlled trial (RCT) consistent with other RCTs ...
  • It’s time to use an age-based approach to D-dimer 

    Urban, Karli; Kirley, Kate; Stevermer, James J. (Family Physicians Inquiries Network, 2014-03)
    Use an age-adjusted D-dimer cutoff (patient’s age in years × 10 mcg/L) for patients over age 50 years when evaluating for venous thromboembolism (VTE); it reduces false positives without substantially increasing false negatives.
  • Prescribing an antibiotic? Pair it with probiotics 

    Rodgers, Blake; Kirley, Kate; Mounsey, Anne L. (Family Physicians Inquiries Network, 2013-03)
    Recommend that patients taking antibiotics also take probiotics, which have been found to be effective both for the prevention and treatment of antibiotic-associated diarrhea (AAD). Strength of recommendation: A: Based ...
  • Think twice about nebulizers for asthma attacks 

    Kirley, Kate; Nguyen, Liz (Family Physicians Inquiries Network, 2014-06)
    MDIs with spacers are as effective as nebulizers for delivering beta-agonists and less likely to cause adverse effects. Practice changer: Stop ordering nebulizers to deliver beta-agonists to patients over age 2 with mild ...
  • Time to try this warfarin alternative? 

    Kirley, Kate; Rowland, Kate (Family Physicians Inquiries Network, 2011-04)
    Consider dabigatran, an oral anticoagulant that does not require monitoring, for the prevention of stroke and thromboembolism in patients with atrial fibrillation. Strength of Recommendation B: Based on a single well-done ...